- CDK4/6i-Based Therapies in HR+ mBC: Optimizing Treatment Selection
- Treatment Sequencing in Advanced/Metastatic Breast Cancer
- Antibody-Drug Conjugates (ADC) in HR+ and TNBC
- Top Insights for HER2+ Breast Cancer
- Real World Oncology: Translating Data to Clinical Practice
- Live Q&A
OncLive® State of the Science Summit™: Breast Cancer
el PRADO Hotel
520 Cowper St, Palo Alto, CA 94301
United States
Wednesday, March 25, 2026
6:00 PM-9:00 PM PDT
Complimentary Parking
In-Person Only
Event Chair
Melinda L. Telli, MD
Stanford University School of Medicine
OVERVIEW
OncLive® State of the Science Summit™ (SOSS) are in-person meetings designed for academic & community-based physicians and health care professionals that provide education on the science driving updates in cancer management and the associated clinical benefits for patients. SOSS attendees will improve their knowledge of novel treatment approaches and reinforce their confidence in applying state-of-the-art treatment strategies.
Registration for this Summit is complimentary.
TOPICS INCLUDE:
Venue Location
OncLive - an MJH Life Sciences brand
Copyright 2025 (C) Intellisphere, LLC
259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831